| __timestamp | Lantheus Holdings, Inc. | Pfizer Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 72429000 | 14097000000 |
| Thursday, January 1, 2015 | 78634000 | 14809000000 |
| Friday, January 1, 2016 | 75374000 | 14837000000 |
| Sunday, January 1, 2017 | 92157000 | 14784000000 |
| Monday, January 1, 2018 | 93326000 | 14455000000 |
| Tuesday, January 1, 2019 | 103132000 | 14350000000 |
| Wednesday, January 1, 2020 | 110171000 | 11615000000 |
| Friday, January 1, 2021 | 218817000 | 12703000000 |
| Saturday, January 1, 2022 | 233827000 | 13677000000 |
| Sunday, January 1, 2023 | 267194000 | 14771000000 |
| Monday, January 1, 2024 | 14730000000 |
Unlocking the unknown
In the ever-evolving pharmaceutical landscape, understanding the financial dynamics of industry leaders is crucial. Over the past decade, Pfizer Inc. and Lantheus Holdings, Inc. have showcased contrasting trajectories in their Selling, General, and Administrative (SG&A) expenses. While Pfizer's SG&A expenses have remained relatively stable, averaging around $14 billion annually, Lantheus has experienced a dramatic rise, with expenses growing by over 270% from 2014 to 2023. This surge reflects Lantheus's aggressive expansion and strategic investments. In 2023, Lantheus's SG&A expenses reached nearly 2% of Pfizer's, highlighting the scale difference but also the rapid growth of Lantheus. As the pharmaceutical industry continues to innovate, these financial insights provide a window into the strategic priorities and market positioning of these two influential companies.
AbbVie Inc. vs Lantheus Holdings, Inc.: SG&A Expense Trends
Cost Management Insights: SG&A Expenses for Pfizer Inc. and Sanofi
Pfizer Inc. and Blueprint Medicines Corporation: SG&A Spending Patterns Compared
SG&A Efficiency Analysis: Comparing Pfizer Inc. and BioMarin Pharmaceutical Inc.
Pfizer Inc. and Geron Corporation: SG&A Spending Patterns Compared
Comparing SG&A Expenses: Zoetis Inc. vs Lantheus Holdings, Inc. Trends and Insights
Cost Management Insights: SG&A Expenses for Lantheus Holdings, Inc. and Opthea Limited
Selling, General, and Administrative Costs: Lantheus Holdings, Inc. vs CymaBay Therapeutics, Inc.
Who Optimizes SG&A Costs Better? Lantheus Holdings, Inc. or Rhythm Pharmaceuticals, Inc.
Breaking Down SG&A Expenses: Lantheus Holdings, Inc. vs ACADIA Pharmaceuticals Inc.
Lantheus Holdings, Inc. and Wave Life Sciences Ltd.: SG&A Spending Patterns Compared
Lantheus Holdings, Inc. and Xencor, Inc.: SG&A Spending Patterns Compared